Patent · US Active

Peptide slow-release formulations

US9974861B2 · kind B2 · utility

2Cited by
18References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2008
Grant dateMay 22, 2018
Priority date
Expiry dateAug 25, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to formulation precursors (pre-formulations) for the in situ generation of compositions for the controlled release of the salts of peptide active agents, including somatostatin analogues. The invention also relates to pre-formulations of amphiphilic components and at least one salt of a peptide active agent (e.g., somatostatin analogue) for parenteral application.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.